Cervical Cancer
News
Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers
(03/31/2008)
Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison studies in gynecological cancers difficult to interpret. These findings were reported in the Journal of the National Cancer Institute.
Neulasta® on First Day of Chemotherapy May Be More Convenient for Gynecologic Cancers
(03/17/2008)
The administration of the blood cell growth factor Neulasta® (pegfilgrastim) on the first day of chemotherapy among women with gynecologic cancers may be as effective as and more convenient than second-day administration. These results were recently reported at the 2008 annual Society of Gynecologic Oncologists meeting.
Liquid-based Cytology No More Accurate than Conventional Pap Test for Cervical Screening
(01/03/2008)
For the detection of cervical abnormalities, liquid-based cytology does not appear to be more accurate than the conventional Pap test. This was the conclusion of a combined analysis published in the journal Obstetrics and Gynecology.
PET Scans May Prove Useful for Predicting Cervical Cancer Outcome
(11/27/2007)
According to the results of a study published in the Journal of the American Medical Association, post-treatment imaging with positron emission tomography (PET) may provide important information about response to cervical cancer treatment and likelihood of survival.
Increased Risk of Cervical Cancer with Oral Contraceptive Use
(11/14/2007)
According to an article recently published in The Lancet, the use of combined oral contraceptives (estrogen and progestin) temporarily increases the risk of cervical cancer. However, this risk remains small: one extra person per 1,000 is diagnosed with cervical cancer with use of the contraceptives.
More
Cervical Cancer
Cancer News...